Trunkstability: a Predisposition for Armfunction
Launched by UNIVERSITY GHENT · Dec 2, 2022
Trial Information
Current as of February 05, 2025
Completed
Keywords
ClinConnect Summary
Fifty healthy subjects will execute a reaching movement in sitting. They will reach to a cone at a distance of little more than armlength.
Electromyogram (EMG) and kinematics will be the outcome measures. Secondary outcome measures are: sex, dexterity, skillfulness, Fifty first time stroke patients will execute the same movements. Primery outcome is EMG and kinematics; secundary outcome measures are: side of hemiplegia, arm recuperation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • BMI \< 30
- • no orthopedic, neurologic disorder that can influence the reaching
- • age between 18 and 70 yrs
- Exclusion Criteria:
- • BMI\>30
- • orthopedic, neurologic disorder that can influence the reaching
- • \< 18 yrs of age
- • \>70 yrs of age
About University Ghent
University Ghent is a prestigious Belgian research institution renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a multidisciplinary approach, the university fosters collaboration among leading experts in various fields, ensuring rigorous study design and ethical standards. University Ghent is dedicated to exploring new therapeutic modalities and enhancing healthcare outcomes, making significant contributions to both local and global health landscapes. Its state-of-the-art facilities and emphasis on research excellence position it as a pivotal sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gent, Oost Vlaanderen, Belgium
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials